Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs

Organogenesis Inc.
Posted on: 05 Apr 18
Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs Dr. Shabnam Vaezzadeh Joins Organogenesis Leadership Team in Strategic Medical Direction Role

PR Newswire

CANTON, Mass., April 5, 2018

CANTON, Mass., April 5, 2018 /PRNewswire/ -- Shabnam Vaezzadeh, MD, MPA, formerly of Acelity, KCI, and Johnson & Johnson LifeScan, has joined Organogenesis Inc. as Vice President of Global Medical & Clinical Affairs, the company announced today.

"We are pleased to welcome Dr. Vaezzadeh to our leadership team," said Patrick Bilbo, Chief Operating Officer of Organogenesis. "Having led impactful medical and clinical affairs programs for some of today's leading life sciences companies, Dr. Vaezzadeh brings invaluable expertise to our company and product portfolio."

As Vice President of Global Medical & Clinical Affairs, Dr. Vaezzadeh is responsible for providing strategic medical direction for the Organogenesis product portfolio. She also oversees the company's Clinical & Health Economics/Outcomes Research, Medical Science Liaison, Pharmacovigilance, Medical Communications, and Customer Medical Information Center functions, executing high-quality, strategic medical and clinical programs to highlight a range of clinical evidence and economic outcomes.

"I am delighted to have joined the astute leadership team of Organogenesis," said Dr. Vaezzadeh. "Leading the medical and clinical teams of this well-respected company, with an innovative therapeutic portfolio that truly impacts patients' lives, is a rewarding undertaking."

Dr. Vaezzadeh has nearly two decades of experience in the life sciences industry, having most recently served as Vice President of Global Medical Affairs at Acelity, where she led several initiatives to expand safe and effective marketplace introduction of surgical and wound care products around the world. Dr. Vaezzadeh started her tenure at Acelity by joining Kinetic Concepts Inc., holding the positions of Vice President of Global Medical Affairs, with global medical affairs and clinical development responsibilities, and Director of Global Safety. Previously, she held product safety surveillance positions at Johnson & Johnson's LifeScan division, where she was involved in product development and post-market surveillance, and was responsible for global pharmacovigilance and health hazard evaluations.

Dr. Vaezzadeh has written and lectured extensively on medical affairs, product safety, and medical device development. She holds a Doctorate in Medicine from the University of Tehran and an M.P.A. in Health Systems Administration from the University of San Francisco.

About Organogenesis
Organogenesis Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehesensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit

Media Contact: 
Angelyn Lowe
(781) 830-2353


View original content with multimedia:

SOURCE Organogenesis Inc.

PR Newswire

Last updated on: 05/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.